• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳大利亚百日咳杆菌缺乏百日咳毒素菌株迅速增加。

Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia.

作者信息

Lam Connie, Octavia Sophie, Ricafort Lawrence, Sintchenko Vitali, Gilbert Gwendolyn L, Wood Nicholas, McIntyre Peter, Marshall Helen, Guiso Nicole, Keil Anthony D, Lawrence Andrew, Robson Jenny, Hogg Geoff, Lan Ruiting

出版信息

Emerg Infect Dis. 2014 Apr;20(4):626-33. doi: 10.3201/eid2004.131478.

DOI:10.3201/eid2004.131478
PMID:24655754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3966384/
Abstract

Acellular vaccines against Bordetella pertussis were introduced in Australia in 1997. By 2000, these vaccines had replaced whole-cell vaccines. During 2008-2012, a large outbreak of pertussis occurred. During this period, 30% (96/320) of B. pertussis isolates did not express the vaccine antigen pertactin (Prn). Multiple mechanisms of Prn inactivation were documented, including IS481 and IS1002 disruptions, a variation within a homopolymeric tract, and deletion of the prn gene. The mechanism of lack of expression of Prn in 16 (17%) isolates could not be determined at the sequence level. These findings suggest that B. pertussis not expressing Prn arose independently multiple times since 2008, rather than by expansion of a single Prn-negative clone. All but 1 isolate had ptxA1, prn2, and ptxP3, the alleles representative of currently circulating strains in Australia. This pattern is consistent with continuing evolution of B. pertussis in response to vaccine selection pressure.

摘要

1997年,澳大利亚引入了针对百日咳博德特氏菌的无细胞疫苗。到2000年,这些疫苗已取代了全细胞疫苗。在2008 - 2012年期间,发生了一次大规模百日咳疫情。在此期间,30%(96/320)的百日咳博德特氏菌分离株不表达疫苗抗原百日咳黏附素(Prn)。记录了多种Prn失活机制,包括IS481和IS1002破坏、同聚物区域内的变异以及prn基因的缺失。在16株(17%)分离株中,无法在序列水平确定Prn表达缺失的机制。这些发现表明,自2008年以来,不表达Prn的百日咳博德特氏菌多次独立出现,而非通过单个Prn阴性克隆的扩增。除1株分离株外,所有分离株均具有ptxA1、prn2和ptxP3,这些等位基因代表了澳大利亚目前流行菌株。这种模式与百日咳博德特氏菌在疫苗选择压力下持续进化一致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/927b/3966384/fa3fb952f3a0/13-1478-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/927b/3966384/aeb303651202/13-1478-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/927b/3966384/2babce7bdca5/13-1478-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/927b/3966384/fa3fb952f3a0/13-1478-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/927b/3966384/aeb303651202/13-1478-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/927b/3966384/2babce7bdca5/13-1478-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/927b/3966384/fa3fb952f3a0/13-1478-F3.jpg

相似文献

1
Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia.澳大利亚百日咳杆菌缺乏百日咳毒素菌株迅速增加。
Emerg Infect Dis. 2014 Apr;20(4):626-33. doi: 10.3201/eid2004.131478.
2
Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013-2017.2013-2017 年澳大利亚无 pertactin 阴性和无丝状血凝素阴性百日咳博德特氏菌。
Emerg Infect Dis. 2019 Jun;25(6):1196-1199. doi: 10.3201/eid2506.180240.
3
Pertactin-deficient isolates: evidence of increased circulation in Europe, 1998 to 2015.无荚膜缺失株:1998 年至 2015 年在欧洲循环增加的证据。
Euro Surveill. 2019 Feb;24(7). doi: 10.2807/1560-7917.ES.2019.24.7.1700832.
4
Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model.百日咳杆菌丝状血凝素阴性菌株在混合感染模型的疫苗选择压力下表现出更高的适应性。
Vaccine. 2015 Nov 17;33(46):6277-81. doi: 10.1016/j.vaccine.2015.09.064. Epub 2015 Oct 2.
5
Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge model.百日咳毒素和丝状血凝素基因型变化对小鼠鼻内攻击模型中无细胞百日咳疫苗适应性的协同作用。
Clin Vaccine Immunol. 2010 May;17(5):807-12. doi: 10.1128/CVI.00449-09. Epub 2010 Mar 31.
6
Pertactin-deficient Bordetella pertussis isolates in Poland-a country with whole-cell pertussis primary vaccination.波兰全细胞百日咳疫苗初免国家中 pertactin 缺陷型百日咳博德特氏菌分离株。
Microbes Infect. 2019 Apr-May;21(3-4):170-175. doi: 10.1016/j.micinf.2018.12.001. Epub 2018 Dec 21.
7
Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin.缺乏百日咳黏附素和百日咳毒素的百日咳博德特氏菌菌株
Emerg Infect Dis. 2016 Feb;22(2):319-322. doi: 10.3201/eid2202.151332.
8
Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage.无荚膜百日咳博德特氏菌阴性菌株:可能具有选择优势的证据。
Clin Infect Dis. 2015 Jan 15;60(2):223-7. doi: 10.1093/cid/ciu788. Epub 2014 Oct 9.
9
Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.百日咳博德特氏菌和缺乏百日咳黏附素的临床分离株:百日咳疫苗的经验教训
Expert Rev Vaccines. 2014 Sep;13(9):1135-46. doi: 10.1586/14760584.2014.932254. Epub 2014 Jun 23.
10
Rare Detection of Bordetella pertussis Pertactin-Deficient Strains in Argentina.阿根廷罕见检测到百日咳博德特氏菌无 pertactin 缺陷菌株。
Emerg Infect Dis. 2019 Nov;25(11):2048-2054. doi: 10.3201/eid2511.190329.

引用本文的文献

1
Resurgence of pertussis: whopping the '100-day cough'.百日咳的死灰复燃:战胜“百日咳”
Curr Opin Pediatr. 2025 Oct 1;37(5):508-516. doi: 10.1097/MOP.0000000000001486. Epub 2025 Aug 21.
2
Vaccine antigen-based genotyping of by direct Sanger sequencing of clinical samples in Peru from 2018 to 2019.2018年至2019年期间,通过对秘鲁临床样本进行直接桑格测序,基于疫苗抗原进行基因分型。
Microbiol Spectr. 2025 Jun 3;13(6):e0200424. doi: 10.1128/spectrum.02004-24. Epub 2025 May 14.
3
Sharp rise in high-virulence Bordetella pertussis with macrolides resistance in Northern China.

本文引用的文献

1
Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.美国百日咳杆菌中缺乏丝状血凝素的百日咳博德特氏菌的流行情况及分子特征
Clin Vaccine Immunol. 2014 Feb;21(2):119-25. doi: 10.1128/CVI.00717-13. Epub 2013 Nov 20.
2
Virulence of pertactin-negative Bordetella pertussis isolates from infants, France.来自法国婴儿的无 pertactin 百日咳博德特氏菌分离株的毒力。
Emerg Infect Dis. 2013 Mar;19(3):471-4. doi: 10.3201/1903.121475.
3
Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin.
中国北方高毒力百日咳博德特氏菌对大环内酯类药物耐药性急剧上升。
Emerg Microbes Infect. 2025 Dec;14(1):2475841. doi: 10.1080/22221751.2025.2475841. Epub 2025 Mar 18.
4
Genomic epidemiology and evolution of under the vaccination pressure of acellular vaccines in Beijing, China, 2020-2023.2020 - 2023年中国北京无细胞疫苗接种压力下的基因组流行病学及演变
Emerg Microbes Infect. 2025 Dec;14(1):2447611. doi: 10.1080/22221751.2024.2447611. Epub 2025 Jan 8.
5
Screening of Novel Drug Targets and Drug Design for : A Subtractive Proteomics Approach.新型药物靶点的筛选与药物设计:一种消减蛋白质组学方法
Curr Res Microb Sci. 2024 Oct 19;7:100291. doi: 10.1016/j.crmicr.2024.100291. eCollection 2024.
6
Deciphering epidemiology through culture-independent multiplex amplicon and metagenomic sequencing.通过非培养多重扩增子和宏基因组测序解析流行病学
J Clin Microbiol. 2024 Dec 11;62(12):e0117824. doi: 10.1128/jcm.01178-24. Epub 2024 Nov 4.
7
Epidemiological characteristics and survival analysis of pertussis in Quzhou.衢州市百日咳的流行病学特征和生存分析。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2420448. doi: 10.1080/21645515.2024.2420448. Epub 2024 Oct 30.
8
[Pertussis worldwide. Vaccinating children and adults].[全球百日咳。为儿童和成人接种疫苗]
Med Trop Sante Int. 2023 Nov 22;3(4). doi: 10.48327/mtsi.v3i4.2023.446. eCollection 2023 Dec 31.
9
Comparative Evaluation of Recombinant and Acellular Pertussis Vaccines in a Murine Model.重组和无细胞百日咳疫苗在小鼠模型中的比较评估
Vaccines (Basel). 2024 Jan 22;12(1):108. doi: 10.3390/vaccines12010108.
10
The Present and Future Aspects of Life-Long Pertussis Prevention: Narrative Review with Regional Perspectives for Türkiye.终身预防百日咳的现状与未来展望:基于土耳其地区视角的叙述性综述
Infect Dis Ther. 2023 Nov;12(11):2495-2512. doi: 10.1007/s40121-023-00876-0. Epub 2023 Oct 10.
百日咳再现:免疫减弱和病原体适应——同一枚硬币的两面。
Epidemiol Infect. 2014 Apr;142(4):685-94. doi: 10.1017/S0950268813000071. Epub 2013 Feb 13.
4
Pertactin-negative variants of Bordetella pertussis in the United States.美国百日咳博德特氏菌的百日咳杆菌粘附素阴性变体
N Engl J Med. 2013 Feb 7;368(6):583-4. doi: 10.1056/NEJMc1209369.
5
Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland.芬兰未表达疫苗抗原百日咳黏附素的百日咳博德特氏菌菌株的出现情况。
Clin Vaccine Immunol. 2012 Oct;19(10):1703-4. doi: 10.1128/CVI.00367-12. Epub 2012 Aug 22.
6
Population diversity among Bordetella pertussis isolates, United States, 1935-2009.1935-2009 年美国百日咳博德特氏菌分离株的人群多样性。
Emerg Infect Dis. 2012 Aug;18(8):1248-55. doi: 10.3201/eid1808.120082.
7
Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin.法国百日咳博德特氏菌和副百日咳博德特氏菌分离株的进化:不表达 pertactin 的博德特氏菌增加。
Clin Microbiol Infect. 2012 Sep;18(9):E340-6. doi: 10.1111/j.1469-0691.2012.03925.x. Epub 2012 Jun 21.
8
Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia.在澳大利亚创纪录的百日咳流行之前,幼儿中低百日咳毒素抗体水平的人群流行率增加。
PLoS One. 2012;7(4):e35874. doi: 10.1371/journal.pone.0035874. Epub 2012 Apr 27.
9
Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008-2010.新出现的携带 prn2 和 ptxP3 等位基因的百日咳博德特氏菌克隆与 2008-2010 年澳大利亚百日咳流行有关。
J Infect Dis. 2012 Apr 15;205(8):1220-4. doi: 10.1093/infdis/jis178. Epub 2012 Mar 13.
10
Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan.日本无 pertactin 缺失百日咳博德特氏菌的流行情况和遗传特征。
PLoS One. 2012;7(2):e31985. doi: 10.1371/journal.pone.0031985. Epub 2012 Feb 14.